|
1) Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1997; 336: 897-904
|
|
|
|
2) Deeg HJ, Socié G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998; 91: 1833-44
|
|
|
|
|
|
3) Baker KS, DeFor TE, Burns LJ, et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003; 21: 1352-8
|
|
|
|
|
|
4) Bhatia S, Louie AD, Bhatia R, et al. Solid cancers after bone marrow transplantation. J Clin Oncol. 2001; 19: 464-71
|
|
|
|
|
|
5) Rizzo JD, Curtis RE, Socié G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009; 113: 1175-83
|
|
|
|
|
|
6) Kolb HJ, Socié G, Duell T, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med. 1999; 131: 738-44
|
|
|
|
|
|
7) Shimada K, Yokozawa T, Atsuta Y, et al. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis. Bone Marrow Transplant. 2005; 36: 115-21
|
|
|
|
|
|
8) Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999; 18: 695-706
|
|
|
|
|
|
9) Klein JP, Rizzo JD, Zhang MJ, et al. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. Bone Marrow Transplant. 2001; 28: 909-15
|
|
|
|
|
|
10) Bhatia S, Ramsay NK, Steinbuch M, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996; 87: 3633-9
|
|
|
|
|
|
11) Curtis RE, Metayer C, Rizzo JD, et al. Impact of chronic GvHD therapy on the development of squamous cell cancers after hematopoietic stem cell transplantation: an international case-control study. Blood. 2005; 105: 3802-11
|
|
|
|
|
|
12) Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2002: based on data from 11 population-based cancer registries. Jpn J Clin Oncol. 2008; 38: 641-8
|
|
|
|
|
13) Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med. 1989; 321: 784-9
|
|
|
|
|
|
14) Curtis RE, Travis LB, Rowlings PA, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999; 94: 2208-16
|
|
|
|
|
|
15) Landgren O, Gilbert ES, Rizzo JD, et al. Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. Blood. 2009; 113: 4992-5001
|
|
|
|
|